Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions
It is the aim of this multicentric clinical study to assess the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions in terms of the reduction of pain and analgesic consumption.
Pain|Neoplasm Metastasis|Cancer
DRUG: Zoledronic acid in combination with therapy
Pain reduction, weekly assessments during 48 weeks
Time to pain reduction, weeks 0, 12, 24, 36, 48 and 60|Duration of pain reduction, weeks 0, 12, 24, 36, 48 and 60|Quality of life, weeks 0, 12, 24, 36, 48 and 60|Changes in parameters of bone turnover, weeks 0, 12, 24, 36, 48 and 60
It is the aim of this multicentric clinical study to assess the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions in terms of the reduction of pain and analgesic consumption.